Terminated NA INTERVENTIONAL 1-arm NCT04710004

Electrophysiological Biomarkers in MTLE Patients.

Electrophysiological Biomarkers During Invasive Monitoring of Mesial Temporal Lobe Epilepsy Patients.

Sponsor: Emory University

Conditions Mesial Temporal Lobe Epilepsy

Interventions Asynchronous distributed multi-electrode stimulation (ADMES) using an implantable neurostimulation device

Updated 10 times since 2021 Last updated: Mar 4, 2024 Started: Nov 30, 2021 Primary completion: Dec 16, 2021 Completion: Dec 16, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Lack of funding to secure effort for testing.

Other terminated trials from Emory University

See all terminations from Emory University

A NA clinical study on Mesial Temporal Lobe Epilepsy, this trial is terminated or withdrawn. The trial is conducted by Emory University and has accumulated 10 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Apr 2024 — Jul 2024 [monthly]

Terminated NA

Status: Recruiting → Terminated
Mar 2023 — Apr 2024 [monthly]

Recruiting NA
Apr 2022 — Mar 2023 [monthly]

Recruiting NA

▶ Show 5 earlier versions

Feb 2022 — Apr 2022 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Sep 2021 — Feb 2022 [monthly]

Not Yet Recruiting NA
Jun 2021 — Sep 2021 [monthly]

Not Yet Recruiting NA
Apr 2021 — Jun 2021 [monthly]

Not Yet Recruiting NA
Feb 2021 — Apr 2021 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Emory University

Data source: Emory University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Atlanta, United States